Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(13%)
Results Posted
20%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
2
25%
Ph not_applicable
1
13%
Ph phase_1
2
25%
Ph phase_3
1
13%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Active, not recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 22 (33.3%)
Phase 31 (16.7%)
N/A1 (16.7%)

Trials by Status

active_not_recruiting113%
unknown113%
completed563%
terminated113%

Recent Activity

1 active trials
Showing 5 of 8
active_not_recruitingphase_1

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

NCT02336087
unknown

Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.

NCT00910884
completed

Women's Healthy Eating and Living Study

NCT00003787
completedphase_1

Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer

NCT00082732
terminatedphase_2

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

NCT00503776
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02336087Phase 1

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

Active Not Recruiting
NCT00910884

Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.

Unknown
NCT00003787

Women's Healthy Eating and Living Study

Completed
NCT00082732Phase 1

Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer

Completed
NCT00503776Phase 2

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Terminated
NCT00020995Phase 2

Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer

Completed
NCT00002564Phase 3

Nutrition Intervention in Treating Women With Breast Cancer

Completed
NCT00739791Not Applicable

Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer

Completed

All 8 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
8